Idiopathic generalized epilepsies (IGE) represent about 20% of all epilepsies, are genetically determined and comprise several subgroups of syndromes. Although complete seizure control is achievable in about 80% of patients with IGE syndromes, a substantial group remains with inadequate control and unsatisfactory long-term outcome. Several new antiepileptic drugs (AEDs) have been studied in children with IGE.
Curatolo, P., Moavero, R., LO CASTRO, A., Cerminara, C. (2009). Pharmacotherapy of idiopathic generalized epilepsies. EXPERT OPINION ON PHARMACOTHERAPY, 10(1), 5-17 [10.1517/14656560802618647].
Pharmacotherapy of idiopathic generalized epilepsies
CURATOLO, PAOLO;MOAVERO, ROMINA;LO CASTRO, ADRIANA;
2009-01-01
Abstract
Idiopathic generalized epilepsies (IGE) represent about 20% of all epilepsies, are genetically determined and comprise several subgroups of syndromes. Although complete seizure control is achievable in about 80% of patients with IGE syndromes, a substantial group remains with inadequate control and unsatisfactory long-term outcome. Several new antiepileptic drugs (AEDs) have been studied in children with IGE.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
